CRYOPORT, INC. Fair Value Adjustment of Warrants
CRYOPORT, INC. (CYRX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2020-03-10
- CRYOPORT, INC. fair value adjustment of warrants for the quarter ending 2019-12-31 was $0.00.
- CRYOPORT, INC. fair value adjustment of warrants for the quarter ending 2019-09-30 was $0.00.
- CRYOPORT, INC. fair value adjustment of warrants for the quarter ending 2019-06-30 was $0.00.
- CRYOPORT, INC. fair value adjustment of warrants for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. fair value adjustment of warrants for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CRYOPORT, INC. fair value adjustment of warrants for fiscal 2018 was $899.41K.
- CRYOPORT, INC. fair value adjustment of warrants for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- CRYOPORT, INC. fair value adjustment of warrants for fiscal 2016 was $4.20M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 derived: sum of 3 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-03-10 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $0.00 derived: sum of 3 quarters · filed 2020-03-10 | $0.00 derived: sum of 4 quarters · filed 2020-03-10 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 derived: sum of 3 quarters · filed 2020-03-10 | $0.00 derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 derived: sum of 3 quarters · filed 2020-03-10 | $899.41K 10-K · filed 2020-03-10 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $899.41K 10-Q · filed 2019-11-12 | $899.41K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $899.41K 10-Q · filed 2019-08-09 | $899.41K derived: sum of 3 quarters · filed 2019-08-09 | $899.41K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $899.41K 10-Q · filed 2019-05-09 | $899.41K derived: sum of 2 quarters · filed 2019-05-09 | $899.41K derived: sum of 3 quarters · filed 2019-05-09 | $899.41K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-13 | $0.00 10-K · filed 2019-03-13 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2018-11-08 | $2.27M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2018-08-09 | $2.27M derived: sum of 3 quarters · filed 2018-05-03 | $2.27M derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-03 | $2.27M derived: sum of 2 quarters · filed 2018-05-03 | $2.27M derived: sum of 3 quarters · filed 2018-05-03 | $4.20M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | $2.27M derived: 10-K 9 month − 10-Q 6 month · filed 2018-03-08 | $2.27M derived: sum of 2 quarters · filed 2018-03-08 | $4.20M 10-K · filed 2018-03-08 | $4.20M 10-K · filed 2018-03-08 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $1.93M 10-Q · filed 2016-11-14 | $1.93M 10-Q · filed 2017-11-02 | $1.93M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-06-30 | $1.93M 10-Q · filed 2017-08-09 | $1.93M 10-Q · filed 2017-08-09 | $1.93M derived: sum of 3 quarters · filed 2017-08-09 | $1.93M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | $0.00 derived: 10-KT 12 month − 10-KT 9 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 derived: sum of 3 quarters · filed 2017-03-13 | $0.00 10-KT · filed 2017-03-13 |
| 2015-12-31 | $0.00 derived: 10-KT 9 month − 10-Q 6 month · filed 2017-03-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-13 | $0.00 10-KT · filed 2017-03-13 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |